These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2326771)

  • 61. Sequential release of eicosanoids during endotoxin-induced shock in anesthetized pigs.
    Mózes T; Zijlstra FJ; Heiligers JP; Saxena PR; Bonta IL
    Prostaglandins Leukot Essent Fatty Acids; 1991 Apr; 42(4):209-16. PubMed ID: 1651510
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A; Ishizaki T; Echizen H; Yasuda K; Fujiwara H; Tanaka T
    Clin Pharmacol Ther; 1992 Apr; 51(4):454-64. PubMed ID: 1563215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of dehydrocorydaline on formation of thromboxane B2 in platelets and 6-keto-pgf1 alpha in rabbit aorta].
    Yang J; Wang YM; Chai RH
    Yao Xue Xue Bao; 1989; 24(6):472-5. PubMed ID: 2609987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlation between pharmacokinetics and pharmacologic effects of a new imidazole thromboxane synthetase inhibitor.
    Iwata T; Mikashima H; Takamatsu R
    J Pharm Sci; 1990 Apr; 79(4):295-300. PubMed ID: 2352139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Plasma level and effects of thromboxane A2 and 6-keto-PGF1 alpha in patients with acute obstructive suppurative cholangitis].
    Miao XY
    Zhonghua Wai Ke Za Zhi; 1990 Apr; 28(4):228-30, 253-4. PubMed ID: 2379443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A therapeutic effect of ulinastatin on endotoxin-induced shock in dogs--comparison with methylprednisolone.
    Okano S; Tagawa M; Urakawa N; Ogawa R
    J Vet Med Sci; 1994 Aug; 56(4):645-9. PubMed ID: 7999884
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
    Kubo K; Kobayashi T
    Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs.
    Fomsgaard JS; Kim YD; Burke TA; Viswanathan T; Schaffer AV; Peppard J; Douglas FL; Danchak M; Myers AK
    Anesth Analg; 1992 Jan; 74(1):38-43. PubMed ID: 1734796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by intravenous administration.
    Kanamaru M; Nakashima M
    J Clin Pharmacol; 1989 Jun; 29(6):563-7. PubMed ID: 2502563
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A study of the role of plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in epidemic hemorrhagic fever].
    Wang GQ; Zou ZZ; Yu DP
    Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):138-40, 188. PubMed ID: 1976492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom.
    Deckmyn H; Van Houtte E; Verstraete M; Vermylen J
    Biochem Pharmacol; 1983 Sep; 32(18):2757-62. PubMed ID: 6578796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits.
    Fink MP; Morrissey PE; Stein KL; Clement RE; Fiallo V; Gardiner WM
    Circ Shock; 1988 Sep; 26(1):41-57. PubMed ID: 3142697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs.
    Morganroth ML; Schoeneich SO; Till GO; Ward PA; Horvath SJ; Glovsky MM
    Am Rev Respir Dis; 1990 Feb; 141(2):296-300. PubMed ID: 2105683
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sudden death induced by intracoronary platelet aggregation.
    Yamazaki H; Isohisa I; Tanoue K
    Jpn Circ J; 1983 May; 47(5):596-607. PubMed ID: 6406715
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horse.
    Semrad SD; Moore JN
    Prostaglandins Leukot Med; 1987 May; 27(2-3):169-81. PubMed ID: 3303061
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitor.
    Ennis C; Granger SE; Middlefell VC; Philpot ME; Shepperson NB
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):511-9. PubMed ID: 2470986
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action.
    Ushiyama S; Ito T; Asai F; Oshima T; Terada A; Matsuda K; Yamazaki M
    Thromb Res; 1988 Sep; 51(5):507-20. PubMed ID: 3175990
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 6-keto-prostaglandin F1 alpha/thromboxane B2 ratio in vascular and lung tissue.
    Saldeen P; Saldeen T
    Thromb Res; 1983 Jun; 30(6):643-50. PubMed ID: 6688484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.